EVGN Stock Analysis: Buy, Sell, or Hold?
EVGN - EVOGENE LTD.
$0.47
-0.01 (-1.25%)
▼
5d:
-10.56%
30d:
+8.24%
90d:
-39.28%
WAIT
LOW Confidence
Analysis Updated: Jul 31, 2026 12:00 AM ET
Earnings: Aug 18, 2026
14d
Get Alerted When EVGN Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
⏸️ WAIT FOR STABILIZATION: EVGN is down 10.6% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.
⏸️ WAIT FOR STABILIZATION: EVGN is down 10.6% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.
In-depth Analysis How we analyze
Valuation Analysis: EVGN is currently trading at $0.47, which is considered fair relative to its 30-day fair value range of $0.43 to $0.55.
Technical Outlook: Technically, EVGN is in a strong downtrend. The price is currently testing key support at $0.46. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: EVGN has a weak technical setup (25/100), with bearish trendlines and momentum suggesting caution for short-term entries. Wall Street analysts see significant upside, with an average price target of $2.15 (+356.5%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, EVGN is in a strong downtrend. The price is currently testing key support at $0.46. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: EVGN has a weak technical setup (25/100), with bearish trendlines and momentum suggesting caution for short-term entries. Wall Street analysts see significant upside, with an average price target of $2.15 (+356.5%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
FAIR
Historical Trading Range
$0.43 -
$0.55
Company Quality Score
41/100
(HOLD)
Volume Confirmation
MODERATE
Confidence Score
44.7%
All Signals
- NEUTRAL: Price in fair range
- BEARISH: Weak technical setup (25/100)
- BULLISH: Trading 356.5% below Wall St target ($2.15)
Trading Range Analysis
30-Day Trading Range
$0.43 -
$0.55
Current vs Trading Range
FAIR
Support & Resistance Levels
Support Level
$0.46
Resistance Level
$0.62
Current Trend
Strong Downtrend
Technical data as of
Jul 31, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-0.59
Wall Street Target
$2.15
(+356.5%)
Revenue Growth (YoY)
-86.3%
Share & Embed Analysis
Last updated: August 03, 2026 12:31 PM ET
Data refreshes hourly during market hours. Next update: 1:31 PM
Data refreshes hourly during market hours. Next update: 1:31 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is EVGN showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
ONC
BeiGene, Ltd. |
STRONG BUY
24 analysts |
$416 | 53 HOLD |
|
ALNY
Alnylam Pharmaceuticals … |
STRONG BUY
30 analysts |
$386 | 43 HOLD |
|
VRTX
Vertex Pharmaceuticals I… |
BUY
34 analysts |
$557 | 49 HOLD |
|
ASND
Ascendis Pharma AS |
STRONG BUY
16 analysts |
$309 | 54 HOLD |
|
APLS
Apellis Pharmaceuticals … |
BUY
22 analysts |
$41 | 59 HOLD |
